After 10 text and 4 image tests, OpenAI's latest model barely beats GPT-5.1. What are Plus subscribers really getting?

Obsessing over model version matters less than workflow.

Since 2022, OpenAI has been the primary character in the most interesting tech and business story in years. ChatGPT was early ...

Iovance Biotherapeutics continues to make progress with Amtagvi, but Q3'25 revenue growth remains modest and heavily influenced by Proleukin sales. IOVA management is shifting focus from patient ...

Prerequisite: Introduction to Python for Absolute Beginners or some experience using Python. You’ve cleaned and analyzed your data, now learn how to visualize it. Visualizing data is critical for both ...

The era of A.I. propaganda is here — and President Trump is an enthusiastic participant. After nationwide protests this weekend against Mr. Trump’s administration, the president posted an ...

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...

Thinking about learning Python? It’s a pretty popular language these days, and for good reason. It’s not super complicated, which is nice if you’re just starting out. We’ve put together a guide that ...

The Hechinger Report covers one topic: education. Sign up for our newsletters to have stories delivered to your inbox. Consider becoming a member to support our nonprofit journalism. Writing can be ...

Passkeys offer a way of confirming you are who you say you are without remembering a long, complicated password, and in a manner that's resistant to common attacks on passwords like phishing and ...